Search Results
. 48 Palazzo, I. C., Araujo, M. L., Darini, A. L.: First report of vancomycin-resistant Staphylococci isolated from healthy carriers in Brazil. J. Clin. Microbiol., 2005, 43 (1), 179
the detection of Staphylococcus aureus including strains with reduced vancomycin susceptibility from blood culture specimens . Diagn Microbiol Infect Dis . 2011 ; 70 : 404 – 7 . 10.1016/j.diagmicrobio.2011.02.006 23
transferred to the ICU because of multi-organ failure, bilateral pneumonia, and suspicion of lung abscess. Empiric intravenous antibiotic (4.5 g of piperacillin/tazobactam 3 times/day, 1 g of amikacin daily, and 1 g of vancomycin twice/day), and antifungal
, erythromycin, clindamycin, and vancomycin) was performed by Epsilometer test (E-test) according to Clinical and Laboratory Standards Institute guidelines [ 23 ] and by the detection of macrolide-resistance-associated genes ( ermTR , ermB, and mefA ) through
commonly used in human medicine and directed toward different bacterial targets: vancomycin (VA; 30 μg), amikacin (AK; 30 μg), penicillin G (P; 10 units), tetracycline (TE; 30 μg), erythromycin (ERY; 15 μg), gentamicin (CN; 10 μg), clindamycin (DA; 2 μg
performed according to the Clinical and Laboratory Standards Institute (CLSI) guideline by standard disk diffusion method. Antibiotics tested were: cefoxitin (30 μg), tigecycline (15 μg), vancomycin (30 μg), linezolid (30 μg), synercid (quinupristin
.043). Importantly, in the year prior to AMR surveillance, only one MRSA strain resistant to vancomycin and linezolid was isolated in the entire CCS, while in AMR surveillance year all MRSA isolates were susceptible to those two last-line antibiotics
minimum inhibitory concentration (MIC) was determined by the broth microdilution method in relation to 12 agents with the following ranges tested: vancomycin (0.25–32 µg/mL), penicillin (0.12–64 µg/mL), ciprofloxacin (0.25–128 µg/mL), tetracycline (0
aeruginosa (carbapenem-resistant) and members of the Enterobacteriaceae (carbapenemase- or extended spectrum beta-lactamase-producing strains), followed by pathogens with high priority, including vancomycin resistant Enterococcus faecium (VRE
10 weeks by adding ampicillin plus sulbactam (1 g/L; Ratiopharm, Germany), vancomycin (500 mg/L; Cell Pharm, Germany), ciprofloxacin (200 mg/L; Bayer Vital, Germany), imipenem (250 mg/L; MSD, Germany), and metronidazole (1 g/L; Fresenius, Germany) to
